A New Option for Some People With Lung Cancer: What the Approval of Lorlatinib Means for Patients

A New Option for Some People With Lung Cancer: What the Approval of Lorlatinib Means for Patients

The FDA recently approved the drug lorlatinib for the treatment of some non-small cell lung cancer. Doctors talk to SurvivorNet about the significance of this approval.

NOW
PLAYING
What Is the Role of Clinical Trials in Bladder Cancer?
NOW
PLAYING
New Research Underscores Importance of Genetic Testing in Non-Smokers' Lung Cancer Tumors
NOW
PLAYING
Trouble in Bed, Decreased Penis Length ... the Difficult Prostate Cancer Treatment Side Effects Doctors May Not Highlight
NOW
PLAYING
Mother Misdiagnosed with COVID Dies Of Stage IV Lung Cancer
NOW
PLAYING
Immunotherapy Saved Lung Cancer Survivor Oswald Peterson
NOW
PLAYING
Pfizer Issues Nationwide Recall of Anti-Smoking Drug Chantix

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.